![]() |
|
![]() |
| Home | About and More Information | Transporter Data Index |
No substrate information.
No inhibitor information.
| DDI | Implicated Transporter* | Interacting Drug | Affected Drug | AUC | Cmax | CLR | CL/F | t1/2 | Effect on PD | Reference | More Details |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical PK Impact(fold change) | |||||||||||
| 1 | OATs | Cefiderocol | Furosemide | 1.01 | 1.00 | ND | ND | 1.25 | ND | Katsube, 2018 | DDI 1 |
| 2 | OCTs/MATE2K | Cefiderocol | Metformin | 1.05 | 1.09 | ND | NR | 0.88 | ND | Katsube, 2018 | DDI 2 |
| 3 | OATP1B3 | Cefiderocol | Rosuvastatin | 1.18 | 1.25 | ND | NR | 1.21 | Katsube, 2018 | DDI 3 | |
PK = pharmacokinetic
The transporters are implicated by in vitro data and/or studies in humans with genetic polymorphisms of the transporter
DDI = Drug Drug Interaction
PD = pharmacodynamic
ND = not determined
NS = not significant
N/A = information not available
Calculation of Fold Change: fold change in the presence of the interacting drug = (value with interacting drug)/(value without interacting drug)
fold change > 1: increase in pharmacokinetic value
fold change < 1: decrease in pharmacokinetic value